Pyruvate kinase type M2 and its role in tumor growth and spreading

Seminars in Cancer Biology

Volumn 15, Issue 4, 2005, Pages 300-308

  Mazurek, Sybille ^a,b   Boschek, C Bruce ^a   Hugo, Ferdinand ^a,c   Eigenbrodt, Erich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ScheBo Biotech AG   (Germany)

^c Institute of Medical Diagnostics   (Germany)

Author keywords

Glutaminolysis; Oncoproteins; Pyruvate kinase; Tumor M2 PK; Tumor metabolome

Indexed keywords

HYDROGEN; PYRUVATE KINASE;

AGING; CITRIC ACID CYCLE; DIMERIZATION; ENERGY YIELD; ENVIRONMENT; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; METASTASIS; NONHUMAN; NUTRIENT SUPPLY; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR GROWTH;

ANIMALS; CELL DIVISION; HUMANS; NEOPLASMS; PYRUVATE KINASE;

EID: 23044500915     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.04.009     Document Type: Review

References (78)

1. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors Cancer Res 49 1989 6449 6465
2. E. Eigenbrodt, F. Kallinowski, M. Ott, S. Mazurek, and P. Vaupel Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors Anticancer Res 18 1998 3267 3274
3. S. Mazurek, H. Grimm, C.B. Boschek, P. Vaupel, and E. Eigenbrodt Pyruvate kinase type M2: a crossroad in the tumor metabolome Brit J Nutr 87 2002 23 29
4. A. Falus Histamine, part of the metabolome Acta Biol Hung 54 2003 27 34
5. S. Mazurek, and E. Eigenbrodt The tumor metabolome Anticancer Res 23 2003 1149 1154
6. O. Warburg On the origin of cancer cells Science 123 1956 309 314
7. L.J. Reitzer, B.M. Wice, and D. Kennell Evidence that glutamine, not sugar, is the major energy source for cultured HeLa-cells J Biol Chem 254 1979 2669 2676
8. S. Mazurek, A. Michel, and E. Eigenbrodt Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates J Biol Chem 272 1997 4941 4952
9. S. Mazurek, H. Grimm, S. Wilker, S. Leib, and E. Eigenbrodt Metabolic characteristics of different malignant cancer cell lines Anticancer Res 18 1998 3275 3282
10. W.L. McKeehan Glycolysis, glutaminolysis and cell proliferation Cell Biol Int Rep 6 1982 635 650
11. M. Reinacher, and E. Eigenbrodt Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-PK) in tumors of chicken and rat Virchows Arch B Cell Pathol Incl Mol Pathol 37 1981 79 88
12. E. Eigenbrodt, P. Fister, and M. Reinacher New perspectives on carbohydrate metabolism in tumor cells R. Beitner Regulation of carbohydrate metabolism vol. 2 1985 CRC Press Boca Raton, FL 141 179
13. M. Board, S. Humm, and E.A. Newsholme Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells Biochem J 265 1990 503 509
14. I. Freitas, V. Bertone, P. Griffini, P. Accossato, G.F. Baronzio, and P. Pontiggia In situ lactate dehydrogenase patterns as marker of tumour oxygenation Anticancer Res 11 1991 1293 1299
15. E. Eigenbrodt, M. Reinacher, U. Scheefers-Borchel, H. Scheefers, and R.R. Friis Double role of pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells M. Perucho Critical reviews in oncogenesis vol. 3 1992 CRC Press Boca Raton, FL 91 115
16. G.E.J. Staal, and G. Rijksen Pyruvate kinase in selected human tumors T.G. Pretlow T.P. Pretlow Biochemical and molecular aspects of selected cancers vol. 2 1991 Academic Press San Diego 313 337
17. M. Gumińska, J. Ignacak, T. Kȩdryna, and B. Stachurska Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells Acta Biochim Pol 44 1997 711 724
18. H.J. Hacker, P. Steinberg, and P. Bannasch Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/dl-ethionine-supplemented diet Carcinogenesis 19 1998 99 107
19. P. Steinberg, A. Klingelhöffer, A. Schäfer, G. Wüst, G. Weisse, and F. Oesch Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats Virchows Arch 434 1999 213 220
20. C. Lobo, M.A. Ruiz-Bellido, J.C. Aledo, J. Marquez, I. Nunez De Castro, and F.J. Alonso Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells Biochem J 348 2000 257 261
21. V. Goossens, J. Grooten, and W. Fiers The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells J Biol Chem 271 1996 192 196
22. E. Eigenbrodt, U. Gerbracht, S. Mazurek, P. Presek, and R.R. Friis Carbohydrate metabolism and neoplasia: new perspectives for diagnosis and therapy T.G. Pretlow T.P. Pretlow Biochemical and molecular aspects of selected cancers vol. 2 1994 Academic Press San Diego, CA 311 385
23. S. Mazurek, C.B. Boschek, and E. Eigenbrodt The role of phosphometabolites on cell proliferation, energy metabolism, and tumor therapy J Bioenerg Biomembr 29 1997 315 330
24. S. Mazurek, H. Grimm, M. Oehmke, G. Weisse, S. Teigelkamp, and E. Eigenbrodt Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells Anticancer Res 20 2000 5151 5154
25. S. Mazurek, W. Zwerschke, P. Jansen-Dürr, and E. Eigenbrodt Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 Oncogene 20 2001 6891 6898
26. E. Eigenbrodt, and H. Glossmann Glycolysis - one of the keys to cancer? Trends Pharmacol Sci 1 1980 240 245
27. T. Noguchi, H. Inoue, and T. Tanaka The M1- and M2-type isoenzymes of rat pyruvate kinase are produced form the same gene by alternative RNA splicing J Biol Chem 261 1986 13807 13812
28. J. Schneider, K. Neu, H. Grimm, H.-G. Velcovsky, G. Weisse, and E. Eigenbrodt Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring Anticancer Res 22 2002 311 318
29. 2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus FEBS Lett 242 1988 194 198
30. E. Eigenbrodt, S. Mazurek, and R. Friis Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools P. Bannasch D. Kanduc S. Papa J.M. Tager Cell growth and oncogenesis 1998 Birkhäuser Verlag Basel 15 30
31. S. Mazurek, W. Zwerschke, P. Jansen-Dürr, and E. Eigenbrodt Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyuvate kinase type M2 and the glycolytic enzyme complex Biochem J 356 2001 247 256
32. W. Zwerschke, S. Mazurek, P. Massimi, L. Banks, E. Eigenbrodt, and P. Jansen-Dürr Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein Proc Natl Acad Sci USA 96 1999 1291 1296
33. M.W. Hentze Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains? Trends Biochem Sci 19 1994 101 103
34. S. Mazurek, F. Hugo, K. Failing, and E. Eigenbrodt Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells. Role of p36 J Cell Physiol 167 1996 238 250
35. +-binding region (Rossmann Fold) J Biol Chem 270 1995 2755 2763
36. M. Engel, S. Mazurek, E. Eigenbrodt, and C. Welter Phosphoglycerate mutase derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell lines J Biol Chem 279 2004 35803 35812
37. F.R. Garcia-Gonzalo, C. Cruz, P. Muňoz, S. Mazurek, E. Eigenbrodt, and F. Ventura Interaction between HERC1 and M2-type pyruvate kinase FEBS Lett 539 2003 78 84
38. J. Bereiter-Hahn, A. Münnich, and P. Woiteneck Dependence of energy metabolism on the density of cells in culture Cell Struct Funct 23 1998 85 93
39. L.G. Boros, M. Cascante, and W.N. Lee Metabolic profiling of cell growth and death in cancer: applications in drug discovery Drug Discov Today 7 2002 364 372
40. G.C. Yeoh Levels of 2,3-diphosphoglycerate in Friend leukemia cells Nature 285 1980 108 109
41. R.C. Jackson, M.S. Lui, T.J. Boritzki, H.P. Morris, and G. Weber Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and of hepatomas in rats Cancer Res 40 1980 1286 1291
42. T. Ryll, and R. Wagner Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes Biotechnol Bioeng 40 1992 934 946
43. K. Ashizawa, M.C. Willingham, C.M. Liang, and S.Y. Cheng In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate J Biol Chem 266 1991 16842 16846
44. E. Marchut, M. Gumínska, and T. Kȩdryna The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells Acta Biochim Pol 33 1986 7 16
45. S. Kress, A. Stein, P. Maurer, B. Weber, J. Reichert, and A. Buchmann Expression of hypoxia-inducible genes in tumor cells J Cancer Res Clin Oncol 124 1998 315 320
46. D.J. Discher, N.H. Bishopric, X. Wu, C.A. Peterson, and K.A. Webster Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element J Biol Chem 273 1998 26087 26093
47. P.A. Oude Weernink, G. Rijksen, E.M. Mascini, and GE.J. Staal Phosphorylation of pyruvate kinase type K is restricted to the dimeric form Biochim Biophys Acta 1121 1992 61 68
48. J.F. Henderson, and F.W. Scott Inhibition of animal and invertebrate cell growth by naturally occuring purine bases and ribonucleosides Pharmacol Ther 8 1980 539 571
49. E. Rapaport Experimental cancer therapy in mice by adenine nucleotides Eur J Cancer Clin Oncol 24 1988 1491 1497
50. J.L. Rosa, R.P. Casaroli-Marano, A.J. Buckler, S. Vilaro, and M. Barbacid p532, a giant protein related to chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins EMBO J 15 1996 4262 4273
51. F. Hugo, G. Fischer, and E. Eigenbrodt Quantitative detection of tumor M2-PK in serum and plasma Anticancer Res 19 1999 2753 2757
52. H.W. Wechsel, E. Petri, K.H. Bichler, and G. Feil Marker for renal carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK) Anticancer Res 19 1999 2583 2590
53. H. Cerwenka, R. Aigner, H. Bacher, G. Werkgartner, A. El-Shabrawi, and F. Quehenberger TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions Anticancer Res 19 1999 849 851
54. D. Lüftner, J. Mesterharm, C. Akrivakis, R. Geppert, P.E. Petrides, and K.D. Wernecke Tumor M2-pyruvate kinase expression in advanced breast cancer Anticancer Res 20 2000 5077 5082
55. G. Schulze The tumor marker Tumor M2-PK: an application in the diagnosis of gastrointestinal cancer Anticancer Res 20 2000 4961 4964
56. M. Ventrucci, A. Cipolla, C. Racchini, R. Casadei, P. Simoni, and L. Gullo Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer Dig Dis Sci 49 2004 1149 1155
57. B. Zhang, J.Y. Chen, D.-D. Chen, G.-B. Wang, and P. Shen Tumor type M2 pyruvate kinase epxression in gastric cancer, colorectal cancer and controls World J Gastroenterol 10 2004 1643 1646
58. P.D. Hardt, S. Mazurek, M. Toepler, P. Schlierbach, R.G. Bretzel, and E. Eigenbrodt Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer Br J Cancer 91 2004 980 984
59. B. Kaura, R. Bagga, and F.D. Patel Evaluation of the pyruvate kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma J Obstet Gynaecol Res 30 2004 193 196
60. G.M. Oremek, S. Teigelkamp, W. Kramer, E. Eigenbrodt, and K.H. Usadel The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma Anticancer Res 19 1999 2599 2601
61. P.D. Hardt, M. Toepler, B. Ngoumou, J. Rupp, and H.U. Kloer Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening Anticancer Res 23 2003 855 857
62. B.C. Yoo, J.-L. Ku, S.-H. Hong, Y.-K. Shin, S.Y. Park, and H.K. Kim Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines Int J Cancer 108 2004 532 539
63. F. Sánchez-Jiménez, P. Martínez, I. Nunnez de Castro, and J.S. Olavarría The function of redox shuttles during aerobic glycolysis in two strains of Ehrlich ascites tumor cells Biochimie 67 1985 259 264
64. L. López-Alarcón, M.L. Eboli, E. De Liberali, G. Palombini, and T. Galeotti Evidence for the oxidation of glycolytic NADH by the malate aspartate shuttle in Ehrlich Ascites Tumor cells Arch Biochem Biophys 192 1979 391 395
65. H. Rübsamen, K. Saltenberger, R.R. Friis, and E. Eigenbrodt Cytosolic malic dehydrogenase activity is associated with a putative substrate for transforming gene product of Rous sarcoma virus Proc Natl Acad Sci USA 79 1982 228 232
66. E. Boitier, M. Merad-Boudia, C. Guguen-Guillouzo, N. Defer, I. Ceballos-Picot, and J.P. Leroux Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals Cancer Res 55 1995 3028 3035
67. T. Matsuno Pathway of glutamate oxidation and its regulation in HuH13 line of human hepatoma cells J Cell Physiol 148 1991 290 294
68. K. Brand, W. Leibold, P. Luppa, C. Schoerner, and A. Schulz Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism Immunobiology 173 1986 23 34
69. T.J. Piva, and E. McEvoy-Bowe Oxidation of glutamine in HeLa cells: role and control of truncated TCA cycles in tumour mitochondria J Cell Biochem 68 1998 213 225
70. H.P. Eck, P. Drings, and W. Dröge Plasma glutamate levels, lymphocyte reactivity and death in patients with bronchial carcinoma J Cancer Res Clin Oncol 115 1989 571 574
71. H. Grimm, A. Tibell, B. Norrlind, C. Blecher, S. Wilker, and K. Schwemmle Immunoregulation by parental lipids: impact of the n-3 to n-6 fatty acid ratio J Parenter Enteral Nutr 18 1994 417 421
72. W.G. Jiang, R.P. Bryce, and D.F. Horrobin Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications Crit Rev Oncol Hematol 27 1998 179 209
73. W. Zwerschke, S. Mazurek, P. Stöckl, E. Hütter, E. Eigenbrodt, and P. Jansen-Dürr Metabolome analysis of senescent human fibroblasts reveals a role for adenosine monophosphate in cellular aging Biochem J 376 2003 403 411
74. J.L. Bos The ras gene family and human carcinogenesis Mutat Res 195 1988 255 271
75. H.E. Ruley Transforming collaborations between ras and nuclear oncogenes Cancer Cells 2 1990 258 268
76. INK4a Cell 88 1997 593 602
77. D.L. Stoler, N. Chen, M. Basik, M.S. Kahlenberg, M.A. Rodriguez-Bigas, and N.J. Petrelli The onset and extent of genomic instability in sporadic colorectal tumor progression Proc Natl Acad Sci USA 96 1999 15121 15126
78. V. Le Mellay, R. Houben, J. Troppmair, C. Hagemann, S. Mazurek, and U. Frey Regulation of glycolysis by Raf protein serine/threonine kinases Adv Enzyme Regul 42 2002 317 332